New Ponazuril Loading Dose Examined for EPM Treatment (AAEP 2012)
Christy Corp-Minamiji, DVM
February 10, 2013
Achieving therapeutic drug levels sooner using a loading dose could minimize S. neurona-caused damage.
Achieving therapeutic drug levels sooner using a loading dose could minimize S. neurona-caused damage.
Industry stakeholders met discuss creating uniform equine medication policy between states.
The FEI Tribunal delivered a record number of equine doping decisions during the first ten months of 2012.
The guild cited improved rider safety when they voted to support racehorse medication reform.
Studies show a wide range in pharmaceutical equivalence of compounded drugs compared to brand name drugs.
A group of researchers and the Thoroughbred Owners of California issued a statement supporting furosemide use.
A review of violation records reveals that fewer Bute overages are occurring at a lower medication threshold.
The legislation calls for a ban on equine performance-enhancing drugs in horse racing in New York.
Veterinarians must take several steps to minimize the horse’s chances of developing a joint infection.
Many difficult decisions racetrack practitioners encounter are out of their control, one veterinarian says.
A double dose of the drug proved no more effective than a single dose and presented a higher toxicity risk.
Among the recommendations was a prohibition on corticosteroids joint injections within seven days of a race.
Many leaders believe sweeping medication reform could become a reality in early 2013.
The changes are designed to prevent mistakes in Salix administration prior to races.
Racing regulators amended rules on the use of clenbuterol and methylprednisolone acetate in Thoroughbreds.
A panel discussed dealing with drug violators in horse racing and reported progress.
Stay on top of the most recent Horse Health news with
